Lichen Simplex Chronicus

• CLINICAL_TRIALS trial_result · 2026-07-02
  Clinical Trial Update: A Study to Investigate Improvement in Pruritus of Lichen Simplex Chronicus With Dupilumab Injections Compared With Placebo in Male and Female Participants Aged at Least 18 Years (STYLE 2) [Phase 3]

  Phase 3 trial investigating dupilumab for pruritus in adults with lichen simplex chronicus; status active_not_recruiting.

• CLINICAL_TRIALS trial_result · 2026-07-02
  Clinical Trial Update: A Study to Investigate Improvement in Pruritus of Lichen Simplex Chronicus With Dupilumab Injections Compared With Placebo in Male and Female Participants Aged at Least 18 Years (STYLE 1) [Phase 3]

  A Phase 3 trial evaluating dupilumab versus placebo for pruritus in adults with lichen simplex chronicus; status active not recruiting.

• CLINICAL_TRIALS trial_result · 2026-03-09
  Clinical Trial Update: Effect of Extracorporeal Shockwave Therapy on Pruritus in Neurodermatitis Patients [NA]

  A completed clinical trial evaluating extracorporeal shockwave therapy for reducing pruritus in patients with Lichen simplex chronicus.

• CLINICAL_TRIALS research · 2026-02-20
  Clinical Trial Update: VALOR: Vaginal Atrophy & Long-term Observation of Recovery [NA]

  VALOR trial update shows the study on vaginal atrophy and related genitourinary and vulvar conditions is currently recruiting, sponsored by …

• CLINICAL_TRIALS research · 2026-01-21
  Clinical Trial Update: A Study to Investigate Improvement in Pruritus of Lichen Simplex Chronicus With Dupilumab Injections Compared With Placebo in Male and Female Participants Aged at Least 18 Years (STYLE 1) [Phase 3]

  A Phase 3 clinical trial evaluating dupilumab versus placebo for reducing pruritus in adults with lichen simplex chronicus (STYLE 1).

• Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
• CLINICAL_TRIALS research · 2026-01-21
  Clinical Trial Update: A Study to Investigate Improvement in Pruritus of Lichen Simplex Chronicus With Dupilumab Injections Compared With Placebo in Male and Female Participants Aged at Least 18 Years (STYLE 2) [Phase 3]

  Phase 3 clinical trial (STYLE 2) evaluating dupilumab versus placebo for pruritus in adults with lichen simplex chronicus; status is active …

• FDA approval · 2023-12-28
  FDA Approved: CLOBETASOL PROPIONATE ANDA — Original Application (Macleods Pharmaceuticals Limited)

  The FDA approved the original ANDA for clobetasol propionate topical from Macleods Pharmaceuticals Limited, enabling a generic version of th…

• CLINICAL_TRIALS trial_result · 2021-12-28
  Clinical Trial Update: A Study to Assess the Efficacy, Safety, and Tolerability of KPL-716 in Reducing Pruritus in Chronic Pruritic Diseases [Phase 2]

  Phase 2 trial evaluating KPL-716 for reducing pruritus in chronic pruritic diseases completed; results have been posted.

• FDA approval · 2020-08-27
  FDA Approved: HALOBETASOL PROPIONATE — Supplemental Application (Coral Way Pharma, LLC)

  FDA approved a supplemental application for halobetasol propionate filed by Coral Way Pharma, LLC.

• CLINICAL_TRIALS trial_result · 2019-10-30
  Clinical Trial Update: Diagnostic Accuracy of "Three Rings Vulvoscopy" for Detection of Vulvar Dermatosis [NA]

  A completed clinical trial evaluating the diagnostic accuracy of Three Rings Vulvoscopy for vulvar dermatoses, with results posted in 2019.

• FDA approval · 2019-10-02
  FDA Approved: CLOBETASOL PROPIONATE — Original Application (Alembic Pharmaceuticals Limited)

  FDA approved Alembic Pharmaceuticals Limited's original application for clobetasol propionate topical, a high-potency corticosteroid, enabli…

• FDA approval · 2019-09-24
  FDA Approved: CLOBETASOL PROPIONATE — Original Application (Zydus Lifesciences Limited)

  FDA approves the original application for clobetasol propionate topical (generic) by Zydus Lifesciences Limited, adding another generic opti…

• FDA approval · 2019-09-06
  FDA Approved: CLOBETASOL PROPIONATE — Supplemental Application (Sun Pharmaceutical Industries, Inc.)

  FDA approved a supplemental application for clobetasol propionate from Sun Pharmaceutical Industries under an ANDA.

• FDA approval · 2018-04-17
  FDA Approved: CLOBETASOL PROPIONATE — Original Application (Xiromed, LLC)

  FDA approved the original application for clobetasol propionate (topical) by Xiromed, LLC. It is a potent corticosteroid indicated for corti…

• FDA approval · 2018-03-26
  FDA Approved: CLOBETASOL PROPIONATE — Original Application (Glenmark Pharmaceuticals Inc., USA)

  FDA approved a generic clobetasol propionate topical product from Glenmark Pharmaceuticals (ANDA 209004) for treatment of inflammatory and p…

• FDA approval · 2017-10-27
  FDA Approved: CLOBETASOL PROPIONATE — Original Application (Zydus Pharmaceuticals USA Inc.)

  FDA approved the original ANDA for a generic clobetasol propionate topical product from Zydus Pharmaceuticals USA Inc.

• FDA approval · 2017-03-20
  FDA Approved: CLOBETASOL PROPIONATE — Original Application (Northstar Rx LLC)

  FDA approved the original application for a generic clobetasol propionate topical corticosteroid, manufactured by Northstar Rx LLC. The appr…

• FDA approval · 2016-04-15
  FDA Approved: CLOBEX — Supplemental Application (Galderma Laboratories, L.P.)

  The FDA approved a supplemental application for CLOBEX (clobetasol propionate) from Galderma Laboratories, L.P. This action typically accomp…

• FDA label_change · 2015-06-29
  FDA Approved: CLOBETASOL PROPIONATE — Supplemental Application (Actavis Pharma, Inc.)

  FDA approves a supplemental application for clobetasol propionate from Actavis Pharma, Inc. to update the product labeling.

• CLINICAL_TRIALS research · 2013-06-05
  Clinical Trial Update: Dapsone Prurigo Study [NA]

  A clinical trial update for a dapsone study in prurigo and lichen simplex chronicus with an unknown status.